[go: up one dir, main page]

GB201811540D0 - Gaucher gene therapy - Google Patents

Gaucher gene therapy

Info

Publication number
GB201811540D0
GB201811540D0 GBGB1811540.2A GB201811540A GB201811540D0 GB 201811540 D0 GB201811540 D0 GB 201811540D0 GB 201811540 A GB201811540 A GB 201811540A GB 201811540 D0 GB201811540 D0 GB 201811540D0
Authority
GB
United Kingdom
Prior art keywords
gaucher
gene therapy
therapy
gene
gaucher gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1811540.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB1811540.2A priority Critical patent/GB201811540D0/en
Publication of GB201811540D0 publication Critical patent/GB201811540D0/en
Priority to PCT/GB2019/050214 priority patent/WO2020012149A1/en
Priority to AU2019300431A priority patent/AU2019300431A1/en
Priority to EP19742885.7A priority patent/EP3820536A1/en
Priority to US17/250,372 priority patent/US20210301304A1/en
Priority to PCT/GB2019/051896 priority patent/WO2020012164A1/en
Priority to IL280165A priority patent/IL280165A/en
Ceased legal-status Critical Current

Links

GBGB1811540.2A 2018-07-13 2018-07-13 Gaucher gene therapy Ceased GB201811540D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB1811540.2A GB201811540D0 (en) 2018-07-13 2018-07-13 Gaucher gene therapy
PCT/GB2019/050214 WO2020012149A1 (en) 2018-07-13 2019-01-25 Glucocerebrosidase gene therapy
AU2019300431A AU2019300431A1 (en) 2018-07-13 2019-01-25 Glucocerebrosidase gene therapy
EP19742885.7A EP3820536A1 (en) 2018-07-13 2019-07-04 Glucocerebrosidase gene therapy
US17/250,372 US20210301304A1 (en) 2018-07-13 2019-07-04 Glucocerebrosidase gene therapy
PCT/GB2019/051896 WO2020012164A1 (en) 2018-07-13 2019-07-04 Glucocerebrosidase gene therapy
IL280165A IL280165A (en) 2018-07-13 2021-01-13 Glucocerebrosidase gene therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1811540.2A GB201811540D0 (en) 2018-07-13 2018-07-13 Gaucher gene therapy

Publications (1)

Publication Number Publication Date
GB201811540D0 true GB201811540D0 (en) 2018-08-29

Family

ID=63273381

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1811540.2A Ceased GB201811540D0 (en) 2018-07-13 2018-07-13 Gaucher gene therapy

Country Status (1)

Country Link
GB (1) GB201811540D0 (en)

Similar Documents

Publication Publication Date Title
IL304084B1 (en) Gene therapy
IL270028B2 (en) Gene therapy
IL274972A (en) Gene therapy for mucopolysaccharidosis iiib
IL280165A (en) Glucocerebrosidase gene therapy
LT3612237T (en) Gene therapy
IL279685A (en) Gene therapy
GB201905301D0 (en) Gene therapy
GB201900702D0 (en) Therapy
IL267057A (en) Gene therapy for mucopolysaccharidosis, type i
GB201707212D0 (en) Gene therapy for ciliopathies
IL287186B1 (en) Monitoring gene therapy
IL267060A (en) Gene therapy for mucopolysaccharidosis, type ii
GB201802326D0 (en) Gene therapy
IL275613A (en) Gene therapy for eosinohilic disorders
GB201817470D0 (en) Gene therapy
GB201918752D0 (en) New therapy
GB201912191D0 (en) New therapy
GB201701968D0 (en) Gene therapy
SG11202110844UA (en) Mixed-cell gene therapy
GB201811540D0 (en) Gaucher gene therapy
GB201820982D0 (en) Gene Therapy
GB201811541D0 (en) Gene therapy
GB201801511D0 (en) Gene therapy
GB201919036D0 (en) Therapy
GB201916983D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)